MYC and Miyoshi myopathy: A better understanding of the mechanisms responsible for MYC deregulation in MM offers the potential for more targeted approaches, given that high dose alkylating agent therapy used in salvage ASCT has shown limited effect on the adverse prognostic impact of MYC rearrangements.